Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Solana Price Rally Eyes $284 Despite Local Top Risks Hinting at a Pullback

Solana Price Rally Eyes $284 Despite Local Top Risks Hinting at a Pullback

BeInCryptoBeInCrypto2025/09/15 03:00
By:Ananda Banerjee

The Solana price is trading near $242 after a strong monthly run, but charts and on-chain data show signs of a short-term pullback. Even so, the path toward $284 remains intact as accumulation trends stay strong.

Solana’s rally has been one of the strongest in the market, with prices climbing nearly 30% month-on-month. At $242 today, the bullish surge for the Solana price toward $284 is still in play.

But charts and on-chain data suggest the move may not be straight up. Short-term signals hint at a pullback that could reset the trend before Solana resumes its climb.

Overheating Signals Point to Only A Pullback as Accumulation Stays Strong

One reason to expect a pause is Solana’s MVRV Z-Score, a valuation metric that compares market value to realized value.

A higher score suggests the asset is leaning toward overvaluation or a local top. On September 12, the MVRV Z-Score spiked to 1.34, its highest in six months. Local peaks in July and August triggered double-digit corrections as they aligned with local Solana price tops.

Solana Price Rally Eyes $284 Despite Local Top Risks Hinting at a Pullback image 0Solana MVRV-Z Score Hints At Correction: Glassnode
  • July 22: MVRV hit 1.03 when SOL was $205. Solana price later corrected to $158, a drop of about 23%.
  • August 13: MVRV peaked at 0.92 when SOL was $201, and price slid to $176, a 12% dip.

This makes the latest high concerning. But the context today is different.

During those earlier local top-induced drops, the exchange net position change turned strongly positive, showing tokens being sent onto exchanges, adding selling pressure.

Solana Price Rally Eyes $284 Despite Local Top Risks Hinting at a Pullback image 1SOL Accumulation Continues: Glassnode

This time, the opposite is true. Since September 10, exchange balances have been deep in the red, meaning SOL continues to flow off exchanges. Persistent outflows suggest accumulation, not panic selling, which may cushion any pullback.

Bearish Pattern Hints at a Solana Price Dip, but the $284 Path Remains Intact

Technical charts add another layer. On the 4-hour chart, Solana shows bearish divergence — price made higher highs, while the RSI (Relative Strength Index), which tracks momentum, made lower highs. On higher timeframes, this pattern often signals trend reversal, but on shorter charts, it usually points to a pullback.

Solana Price Rally Eyes $284 Despite Local Top Risks Hinting at a Pullback image 2Solana Price Chart Shows Bearish Divergence: TradingView

The levels to watch are $239 and $237, which align as supports on both 4-hour and daily charts. Now that the MVRV-Z spike and RSI divergence point to a pullback, it is time to check the daily chart closely for key levels.

Solana Price Rally Eyes $284 Despite Local Top Risks Hinting at a Pullback image 3Solana Price Analysis: TradingView

A slip under $237 could bring $230 and $224 into play. Still, the larger breakout remains valid. The Solana price already broke cleanly above its channel, validating the bullish setup we tracked earlier.

The breakout target sits near $284 per the ascending channel target (a 17% rise from the current levels), and unless SOL falls below $199, that target remains intact.

In other words, a dip here may be less of a threat and more of a reset. For now, Solana’s short-term momentum appears to be strained, but the broader rally toward $284 still looks on track.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Wall Street Stands Guard as Bessent Strikes Again: Aftereffects of August's "Treasury Turnaround" Persist, November Refinancing Notice Could Be the Next Flashpoint

As the US Treasury prepares to update its debt management plan in November, key clues may emerge on Friday.

智通财经•2026/10/16 01:06

"Coca-Cola belief" never goes out of style! KFC in America says goodbye to Pepsi and embraces Coca-Cola (KO.US); Buffett-style "boring investment" returns to the spotlight

KFC has chosen Coca-Cola as its soda supplier in the United States, abandoning its long-term partner Pepsi. As of the close of the U.S. stock market on Thursday, Coca-Cola's (KO.US) stock price reached a record high, defying the ongoing declines in global tech stocks, especially in the semiconductor and broad AI computing sectors.

智通财经•2026/10/16 01:06

AI financing concerns weigh heavily on chip stocks, global tech sector has lost over $1 trillion this week

Multiple pressures, including rising expectations of a Federal Reserve rate hike and increasing AI financing costs, have led to a massive sell-off in global tech stocks this week. The combined market value of the world's top 20 AI and semiconductor stocks has evaporated by more than $1 trillion, and the semiconductor ETF (SOXX) has recorded its longest losing streak in 11 years. On Thursday, SK Hynix continued to plunge by over 10% in a single day, while Nvidia, Samsung, and SoftBank were not spared.

华尔街见闻•2026/10/16 00:51

Safe Haven Amid AI Crash! Major Pharmaceutical Stocks Approach Historic Highs

Amid concerns over AI capital expenditures, funds are seeking a "certainty premium." State Street Healthcare ETF reached a record high. Eli Lilly and AbbVie are both approaching their historical highest closing prices, while Gilead and Amgen have surged 7.7% and 7.2% respectively over the past five days. Eli Lilly continues to bet on the future through its GLP-1 dominance and 40 M&A deals totaling $20 billion. AbbVie's core drug Skyrizi has shown positive data for its new subcutaneous formulation, which is expected to extend its patent and drive additional sales.

华尔街见闻•2026/10/16 00:37
Safe Haven Amid AI Crash! Major Pharmaceutical Stocks Approach Historic Highs